ATA365378A - Verfahren zur herstellung der neuen rechts- drehenden isomeren asymmetrischer spiro- -hydantoine und ihrer metallsalze - Google Patents

Verfahren zur herstellung der neuen rechts- drehenden isomeren asymmetrischer spiro- -hydantoine und ihrer metallsalze

Info

Publication number: ATA365378A
Authority: AT; Austria
Prior art keywords: hydantoins; producing; metal salts; new right; asymmetric spiro
Prior art date: 1977-05-23

Application number

AT783653A

Other languages

English (en)

Other versions

AT357170B (de

Inventor

Reinhard Sarges

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-05-23

Filing date

1978-05-19

Publication date

1979-11-15

1978-05-19 Application filed by Pfizer filed Critical Pfizer

1979-11-15 Publication of ATA365378A publication Critical patent/ATA365378A/de

1980-06-25 Application granted granted Critical

1980-06-25 Publication of AT357170B publication Critical patent/AT357170B/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT365378A 1977-05-23 1978-05-19 Verfahren zur herstellung der neuen rechts- drehenden isomeren asymmetrischer spiro- -hydantoine und ihrer metallsalze AT357170B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/799,586 US4130714A (en)	1977-05-23	1977-05-23	Hydantoin therapeutic agents

Publications (2)

Publication Number	Publication Date
ATA365378A true ATA365378A (de)	1979-11-15
AT357170B AT357170B (de)	1980-06-25

Family

ID=25176274

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT365378A AT357170B (de)	1977-05-23	1978-05-19	Verfahren zur herstellung der neuen rechts- drehenden isomeren asymmetrischer spiro- -hydantoine und ihrer metallsalze

Country Status (37)

Country	Link
US (1)	US4130714A (de)
JP (1)	JPS6035350B2 (de)
AR (1)	AR219531A1 (de)
AT (1)	AT357170B (de)
AU (1)	AU499518B1 (de)
BE (1)	BE867248A (de)
CA (1)	CA1088073A (de)
CH (1)	CH631455A5 (de)
CS (1)	CS200550B2 (de)
DD (1)	DD137107A5 (de)
DE (2)	DE2858042C2 (de)
DK (1)	DK147941C (de)
EG (1)	EG13691A (de)
ES (1)	ES470070A1 (de)
FI (1)	FI62838C (de)
FR (1)	FR2392024A1 (de)
GB (1)	GB1572688A (de)
GR (1)	GR68694B (de)
HK (1)	HK53981A (de)
HU (1)	HU177718B (de)
IE (1)	IE47273B1 (de)
IL (1)	IL54754A (de)
IN (1)	IN147854B (de)
IT (1)	IT1096306B (de)
KE (1)	KE3168A (de)
LU (1)	LU79685A1 (de)
MY (1)	MY8200156A (de)
NL (1)	NL7804158A (de)
NO (1)	NO150206C (de)
NZ (1)	NZ187334A (de)
PH (1)	PH13828A (de)
PL (1)	PL110460B1 (de)
PT (1)	PT68071B (de)
SE (1)	SE437375B (de)
SU (1)	SU873885A3 (de)
YU (1)	YU40829B (de)
ZA (1)	ZA782919B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1088945A (en) *	1976-10-18	1980-11-04	Pfizer Limited	Hydantoin derivatives as therapeutic agents
US4181728A (en) *	1978-11-16	1980-01-01	Pfizer Inc.	Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) *	1979-03-21	1980-01-01	Pfizer Inc.	Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) *	1979-04-19	1980-07-01	Pfizer Inc.	Pharmaceutical preparations containing coumarin carboxylic acid derivatives
IE50332B1 (en) *	1979-11-13	1986-04-02	Ici Ltd	1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof
US4248882A (en) *	1980-02-12	1981-02-03	Pfizer Inc.	Treating diabetes-associated complications with hydantoin amines
US4286098A (en) *	1980-03-28	1981-08-25	Pfizer Inc.	Process for the preparation of chiral hydantoins
JPS5745185A (en) *	1980-07-21	1982-03-13	Eisai Co Ltd	Hydantoin derivative and its preparation
US4419521A (en) *	1981-11-12	1983-12-06	Pfizer Inc.	6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) *	1982-01-20	1983-07-25	Eisai Co Ltd	光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4438272A (en)	1982-04-15	1984-03-20	Alcon Laboratories, Inc.	Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) *	1982-04-15	1985-09-10	Alcon Laboratories, Inc.	Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) *	1982-04-15	1984-08-07	Alcon Laboratories, Inc.	Treatment of diabetic complications with hydantoins
US4436745A (en)	1982-04-15	1984-03-13	Alcon Laboratories, Inc.	Method of inhibiting aldose reductase activity
US4528387A (en) *	1982-11-10	1985-07-09	Pfizer Inc.	Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4431828A (en) *	1982-11-10	1984-02-14	Pfizer Inc.	Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4435578A (en)	1982-11-10	1984-03-06	Pfizer Inc.	Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4556670A (en) *	1982-12-06	1985-12-03	Pfizer Inc.	Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) *	1983-04-27	1984-10-02	Pfizer Inc.	8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4537892A (en) *	1983-09-14	1985-08-27	Alcon Laboratories, Inc.	Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US5153211A (en) *	1983-09-14	1992-10-06	Alcon Laboratories, Inc.	Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
DE3561198D1 (en) *	1984-03-23	1988-01-28	Pfizer	Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4600717A (en) *	1984-04-11	1986-07-15	Alcon Laboratories, Inc.	Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) *	1984-04-11	1988-01-05	Alcon Laboratories, Inc.	Ophthalmic wound healing with aldose reductase inhibitors
JPH06772B2 (ja) *	1984-07-09	1994-01-05	鐘淵化学工業株式会社	３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
HU198212B (en) *	1984-07-20	1989-08-28	Pfizer	Process for production of spiro-imidasolones
US4656169A (en) *	1984-08-14	1987-04-07	Pfizer Inc.	Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
DE3565105D1 (en) *	1984-08-20	1988-10-27	Pfizer	Process for the production as asymmetric hydantoins
US4620019A (en) *	1984-08-23	1986-10-28	Pfizer Inc.	S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) *	1984-09-11	1986-09-02	Alcon Laboratories, Inc.	Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) *	1984-09-26	1985-11-05	Pfizer Inc.	Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US5340829A (en) *	1984-11-20	1994-08-23	Washington Research Foundation	Immunoregulatory agents
US4966911A (en) *	1984-11-20	1990-10-30	Washington Research Foundation	Immunoregulatory agents
JPS61200991A (ja) *	1985-03-04	1986-09-05	Sanwa Kagaku Kenkyusho:Kk	スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (en)	1985-06-14	1986-12-18	Pfizer Inc.	Intermediate in the production of an asymmetric hydantoin
JPS627654U (de) *	1985-06-26	1987-01-17
WO1987004344A1 (en) *	1986-01-17	1987-07-30	Pfizer Inc.	Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) *	1986-08-28	1988-03-12	Sanwa Kagaku Kenkyusho Co Ltd	ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
AU598366B2 (en) *	1987-03-20	1990-06-21	Alcon Laboratories, Inc.	Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes
US4841079A (en) *	1987-08-07	1989-06-20	Pfizer, Inc.	Process for the production of asymmetric hydantoins
US5006657A (en) *	1988-07-27	1991-04-09	Pfizer Inc.	Intermediates in a resolution process for racemic spiro hydantoins
US4952694A (en) *	1988-07-27	1990-08-28	Pfizer Inc.	Novel resolution process for racemic spiro-hydantoins
AU617541B2 (en) *	1988-10-20	1991-11-28	Wyeth	Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
EP0536119A4 (en) *	1989-02-10	1993-08-04	Washington Research Foundation	Immunoregulatory agents
US4980357A (en) *	1990-03-01	1990-12-25	Pfizer Inc.	Azolidinedione derivatives
US5039672A (en) *	1990-04-05	1991-08-13	Pfizer Inc.	Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) *	1990-06-11	1993-08-17	Pfizer Inc.	1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) *	1992-02-18	1993-04-27	Pfizer Inc.	Preparation of optically active spiro-hydantoins
KR950703539A (ko) *	1992-09-28	1995-09-20	알렌 제이. 스피겔	당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
US5521208A (en) *	1993-07-29	1996-05-28	Alcon Laboratories, Inc.	Compositions and methods for the treatment of the metabolically impaired and for improved compliance
CN101239089A (zh) *	1997-04-15	2008-08-13	Csir公司	具有食欲抑制剂活性的药物组合物
GB2396815B (en) *	1999-10-27	2004-09-08	Phytopharm Plc	A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en)	2000-06-30	2004-09-29	Phytopharm Plc	Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
CN1477976A (zh)	2000-11-30	2004-02-25	�Ʒ�	Gaba激动剂与醛糖还原酶抑制剂的组合
US20110092566A1 (en) *	2004-11-19	2011-04-21	Srivastava Satish K	Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en)	2006-08-21	2012-04-17	Kador Peter F	Topical treatment of cataracts in dogs
ATE518544T1 (de)	2007-03-12	2011-08-15	Zadec Aps	Rotbusch-extrakt gegen diabetes
US8273746B2 (en) *	2007-03-23	2012-09-25	The Board Of Regents Of The University Of Texas System	Methods involving aldose reductase inhibitors
US20090270490A1 (en) *	2008-04-24	2009-10-29	The Board Of Regents Of The University Of Texas System	Methods involving aldose reductase inhibition
WO2012088525A2 (en)	2010-12-23	2012-06-28	The Board Of Regents Of The University Of Texas System	Methods for treating copd
UA118035C2 (uk) *	2013-10-07	2018-11-12	Сінгента Партісіпейшнс Аг	Гербіцидні сполуки
US12090142B2 (en)	2018-02-22	2024-09-17	Board Of Regents, The University Of Texas System	Combination therapy for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2683718A (en) *	1952-01-11	1954-07-13	Searle & Co	Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) *	1961-06-29	1962-09-06	Asta Werke Ag Chem Fab	Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) *	1976-10-18	1980-11-04	Pfizer Limited	Hydantoin derivatives as therapeutic agents

1977
- 1977-05-23 US US05/799,586 patent/US4130714A/en not_active Expired - Lifetime
1978
- 1978-03-30 SE SE7803626A patent/SE437375B/sv not_active IP Right Cessation
- 1978-04-15 IN IN272/DEL/78A patent/IN147854B/en unknown
- 1978-04-19 PH PH21026A patent/PH13828A/en unknown
- 1978-04-19 NL NL7804158A patent/NL7804158A/xx active Search and Examination
- 1978-05-11 CS CS783021A patent/CS200550B2/cs unknown
- 1978-05-13 JP JP53057064A patent/JPS6035350B2/ja not_active Expired
- 1978-05-16 PL PL1978206826A patent/PL110460B1/pl unknown
- 1978-05-16 YU YU1169/78A patent/YU40829B/xx unknown
- 1978-05-17 HU HU78PI625A patent/HU177718B/hu not_active IP Right Cessation
- 1978-05-17 SU SU782616255A patent/SU873885A3/ru active
- 1978-05-18 AR AR272227A patent/AR219531A1/es active
- 1978-05-18 DD DD78205450A patent/DD137107A5/de unknown
- 1978-05-18 GB GB20352/78A patent/GB1572688A/en not_active Expired
- 1978-05-19 AT AT365378A patent/AT357170B/de not_active IP Right Cessation
- 1978-05-19 CA CA303,740A patent/CA1088073A/en not_active Expired
- 1978-05-19 DE DE2858042A patent/DE2858042C2/de not_active Expired
- 1978-05-19 BE BE187841A patent/BE867248A/xx not_active IP Right Cessation
- 1978-05-19 DE DE2821966A patent/DE2821966C2/de not_active Expired
- 1978-05-20 EG EG320/78A patent/EG13691A/xx active
- 1978-05-20 GR GR56282A patent/GR68694B/el unknown
- 1978-05-22 ZA ZA00782919A patent/ZA782919B/xx unknown
- 1978-05-22 ES ES470070A patent/ES470070A1/es not_active Expired
- 1978-05-22 NZ NZ187334A patent/NZ187334A/en unknown
- 1978-05-22 IT IT23672/78A patent/IT1096306B/it active
- 1978-05-22 DK DK226778A patent/DK147941C/da not_active IP Right Cessation
- 1978-05-22 LU LU79685A patent/LU79685A1/xx unknown
- 1978-05-22 NO NO781769A patent/NO150206C/no unknown
- 1978-05-22 AU AU36328/78A patent/AU499518B1/en not_active Expired
- 1978-05-22 FI FI781613A patent/FI62838C/fi not_active IP Right Cessation
- 1978-05-22 CH CH552778A patent/CH631455A5/fr not_active IP Right Cessation
- 1978-05-22 IE IE1015/78A patent/IE47273B1/en not_active IP Right Cessation
- 1978-05-22 PT PT68071A patent/PT68071B/pt unknown
- 1978-05-22 IL IL54754A patent/IL54754A/xx not_active IP Right Cessation
- 1978-05-22 FR FR7815032A patent/FR2392024A1/fr active Granted
1981
- 1981-10-15 KE KE3168A patent/KE3168A/xx unknown
- 1981-11-05 HK HK539/81A patent/HK53981A/xx unknown
1982
- 1982-12-30 MY MY156/82A patent/MY8200156A/xx unknown

Also Published As

Publication number	Publication date
IT7823672A0 (it)	1978-05-22
US4130714A (en)	1978-12-19
NO150206B (no)	1984-05-28
SU873885A3 (ru)	1981-10-15
ES470070A1 (es)	1979-01-01
PL110460B1 (en)	1980-07-31
HU177718B (en)	1981-12-28
GR68694B (de)	1982-02-01
DD137107A5 (de)	1979-08-15
FR2392024B1 (de)	1981-07-24
FI62838C (fi)	1983-03-10
SE7803626L (sv)	1978-11-24
DE2821966A1 (de)	1978-11-30
FI781613A7 (fi)	1978-11-24
CA1088073A (en)	1980-10-21
KE3168A (en)	1981-11-06
NO781769L (no)	1978-11-24
DK147941B (da)	1985-01-14
YU116978A (en)	1983-02-28
DK226778A (da)	1978-11-24
ZA782919B (en)	1979-06-27
AR219531A1 (es)	1980-08-29
IE781015L (en)	1978-11-23
PT68071A (en)	1978-06-01
FR2392024A1 (fr)	1978-12-22
IE47273B1 (en)	1984-02-08
PL206826A1 (pl)	1979-04-23
HK53981A (en)	1981-11-13
IN147854B (de)	1980-07-19
LU79685A1 (fr)	1979-12-06
AT357170B (de)	1980-06-25
BE867248A (fr)	1978-11-20
CS200550B2 (en)	1980-09-15
NZ187334A (en)	1984-04-27
DK147941C (da)	1985-08-26
EG13691A (en)	1982-12-31
DE2821966C2 (de)	1983-06-01
MY8200156A (en)	1982-12-31
JPS53144575A (en)	1978-12-15
NL7804158A (nl)	1978-11-27
IL54754A0 (en)	1978-07-31
PH13828A (en)	1980-10-07
IT1096306B (it)	1985-08-26
DE2858042C2 (de)	1983-11-24
GB1572688A (en)	1980-07-30
YU40829B (en)	1986-06-30
FI62838B (fi)	1982-11-30
NO150206C (no)	1984-09-05
CH631455A5 (fr)	1982-08-13
IL54754A (en)	1982-04-30
AU499518B1 (en)	1979-04-26
PT68071B (en)	1979-10-26
JPS6035350B2 (ja)	1985-08-14
SE437375B (sv)	1985-02-25

Publication	Publication Date	Title
AT357170B (de)	1980-06-25	Verfahren zur herstellung der neuen rechts- drehenden isomeren asymmetrischer spiro- -hydantoine und ihrer metallsalze
AT347582B (de)	1979-01-10	Verfahren zur herstellung des neuen 4'- deoxydaunomycins
AT362499B (de)	1981-05-25	Verfahren zur herstellung des neuen anti- biotisch wirksamen deosynarasinkomplexes
AT353277B (de)	1979-11-12	Verfahren zur herstellung des neuen orthophos- phates von 2-isopropylaminopyrimidin
AT360972B (de)	1981-02-10	Verfahren zur herstellung von neuen amino- benzoesaeureamiden und deren salzen
AT358006B (de)	1980-08-11	Verfahren zur herstellung der neuen 4-iso- hexyl-1-methylcyclohexancarbonsaeure
AT351689B (de)	1979-08-10	Verfahren zur herstellung des neuen l- pyroglutamyl-l-prolinamids
AT350071B (de)	1979-05-10	Verfahren zur herstellung des neuen 3,5,5- trimethylhexanoyl-ferrocens
AT374476B (de)	1984-04-25	Verfahren zur herstellung von neuen pyridopyrimidinen sowie deren salzen, hydraten und isomeren
AT362378B (de)	1981-05-11	Verfahren zur herstellung des neuen 3-cyan-n- -(n,n-dimethylaminopropyl)-iminodibenzyls und dessen saeureadditionssalzen
AT344886B (de)	1978-08-10	Verfahren zur herstellung des neuen fortimicin c und seiner salze
AT360037B (de)	1980-12-10	Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT351014B (de)	1979-07-10	Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
AT361925B (de)	1981-04-10	Verfahren zur herstellung des neuen n-6-chlor- nicothinoyl-d,1-homocysteinthiolactons und dessen salzen
AT373238B (de)	1983-12-27	Verfahren zur herstellung des neuen 4-amino-5-
AT368756B (de)	1982-11-10	Verfahren zur herstellung von neuen antitumorglycosiden der anthracyclinreihe
AT360501B (de)	1981-01-12	Verfahren zur herstellung der neuen salze n- -epsilon-trimethyl-l-lysin-monoglutamat, -difumarat oder -diaspartat
AT358189B (de)	1980-08-25	Verfahren zur herstellung von neuen aspidosper- midinen
ATA91780A (de)	1983-12-15	Verfahren zur herstellung des neuen 2-benzyl-3(3-dimethylaminopropylthio)-2h-indazols und von dessen salzen
AT366663B (de)	1982-04-26	Verfahren zur herstellung des neuen dihydrocyclosporin d
ATA246580A (de)	1981-09-15	Verfahren zur herstellung des neuen isocyclosporin d
AT356301B (de)	1980-04-25	Verfahren zur herstellung von neuen d-homo- steroiden
ATA463280A (de)	1981-01-15	Verfahren zur herstellung des neuen 3-cyan-n- -(n,n-dimethylaminopropyl)-iminodibenzyls und dessen saeureadditionssalzen
ATA463180A (de)	1981-01-15	Verfahren zur herstellung des neuen 3-cyan-n- (n,n-dimethylaminopropyl)-iminodibenzyls und dessen saeureadditionssalzen
ATA463380A (de)	1983-12-15	Verfahren zur herstellung des neuen 3-cyan-n-(n,n-dimethylaminopropyl)-iminodibenzy s und dessen saeureadditionssalzen

Legal Events

Date	Code	Title	Description
1985-02-15	ELJ	Ceased due to non-payment of the annual fee
1994-08-15	ELJ	Ceased due to non-payment of the annual fee